| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Edwards Lifesciences Corporation (EW) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 17 sells. EW is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Pres | 215.9K | $18.54M | - | |
| VP | 98.6K | $8.47M | -23,145 | |
| CFO | 46.7K | $4.01M | - | |
| VP | 44.3K | $3.81M | - | |
| VP | 40.4K | $3.47M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 23, 2024 | Gallahue Kieran | Director | Sale+OE | 3,058 | $87.61 | $267,911.38 | -4.4% | -0.3% | -16.5% | |
| Feb 21, 2024 | Chopra Daveen59 | Cvp, Tmtt | Sale+OE | 8,200 | $86.74 | $711,271.74 | -13.5% | +4.3% | -13.8% | |
| Feb 15, 2024 | Szyman Catherine M.67 | Cvp, Critical Care | Sale+OE | 47,000 | $85.98 | $4,040,853.60 | -40.3% | +4.8% | -11.4% | |
| Feb 13, 2024 | Bobo Donald E Jr64 | Cvp,Strategy/ Corp Development | Sale+OE | 11,000 | $85.83 | $944,155.46 | -10.9% | -1.8% | -12.1% | |
| Feb 12, 2024 | Sellers Robert W.A.52 | SVP, Corporate Controller | Sale+OE | 12,210 | $87.00 | $1,062,270.00 | -48.3% | -2.8% | -18.6% | |
| Feb 8, 2024 | Stone Heisz Leslie55 | Director | Sale+OE | 7,056 | $86.45 | $609,991.20 | -20.7% | -0.8% | -18.0% | |
| Feb 5, 2024 | Mussallem Michael A65 | Director | Sale+OE | 29,350 | $87.49 | $2,567,753.55 | -26.7% | -1.1% | -17.1% | |
| Feb 1, 2024 | Ullem Scott B.65 | Cvp, Chief Financial Officer | Sale+OE | 7,255 | $78.29 | $567,993.95 | -27.4% | +7.1% | -8.0% | |
| Jan 12, 2024 | Bobo Donald E Jr64 | Cvp,Strategy/ Corp Development | Sale+OE | 10,000 | $75.67 | $756,700.00 | -20.2% | +23.5% | -0.8% | |
| Jan 5, 2024 | Mussallem Michael A65 | Director | Sale+OE | 29,350 | $72.98 | $2,142,089.00 | -45.0% | +25.2% | +1.5% |